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Free fatty acids are the major energy source for cardiac 
muscle. Oxidation of fatty acid decreases or even ceases 
during ischemia. Its recovery after transient ischemia 
remains largely unexplored. Using intracoronary car-
bon-tt palmitic acid as a tracer of myocardial fatty acid 
metabolism in an open chest dog model, retention and 
clearance of tracer in myocardium were evaluated at 
control, during ischemia and after reperfusion following 
a 20 minute occlusion of the left anterior descending 
coronary artery. Myocardial C-tt time-activity curves 
were analyzed with biexponential curve-fitting routines 
yielding fractional distribution and clearance half-times 
of Call palmitic acid in myocardial tissue. 
In animals with permanent occlusion and intracor-
onary injection of Call palmitic acid distal to the occlu-
sion site, the relative size and half-time of the early clear-
ance curve component differed markedly from control 
values and did not change with ongoing ischemia. Con-
Experimental coronary artery occlusion causes cessation of 
regional function within seconds. If the occlusion is released 
and blood flow restored before irreversible ischemic injury 
occurs, regional function recovers slowly. In the canine 
myocardium, for example, it was shown previously (1,2) 
that regional function was still depressed 72 hours after a 
15 minute occlusion of the left anterior descending coronary 
artery. The phenomenon of slow functional recovery after 
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versely, in animals with only 20 minutes of coronary 
occlusion, the relative size of the early Call clearance 
phase was still significantly depressed at 20 and 90 min-
utes of reperfusion but returned to control level at t80 
minutes. Tissue C-tl clearance half-times remained sig-
nificantly prolonged throughout the reperfusion period. 
Regional function in reperfused myocardium monitored 
with ultrasonic crystals recovered slowly and was still 
less than control after 3 hours of reperfusion. 
The data indicate that after transient ischemia, myo-
cardial fatty acid metabolism fails to recover immedi-
ately. Because the metabolic recovery occurs in parallel 
with recovery of regional function, C-tt palmitic acid 
in conjunction with positron tomography may be useful 
for studying regional fatty acid metabolism noninva-
sively after an ischemic injury, and may be helpful in 
identifying reversible tissue injury. 
(] Am Coli Cardiol 1985;6:311-20) 
a transient ischemic result has been referred to as "stunned 
myocardium" (3). This loss of contractile function is bio-
chemically related to reduced levels of high energy phos-
phates (3), and there is a relation between functional im-
provement and restoration of high energy phosphate stores 
in reperfused canine myocardium (I). High energy phos-
phates are produced primarily in mitochondria through ox-
idati ve metabolism of various substrates by way of the citric 
acid cycle and the electron transport chain. The preferred 
energy substrate of the heart is free fatty acids in the fasting 
state. The oxidation of free fatty acids decreases or ceases 
during ischemia. Although this has been extensively doc-
umented in animal experiments (4), information on the re-
covery of substrate and, specifically, of free fatty acid me-
tabolism during reperfusion after transient ischemia is sparse. 
In vivo evaluation of myocardial metabolism has been 
limited by the required invasive techniques, With the de-
velopment of positron emission tomography, the noninva-
sive assessment of regional metabolism has become possible 
(5). The value of carbon-II palmitic acid for the study of 
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regional myocardial fatty acid metabolism with positron 
emission tomography has been demonstrated in animal ex-
periments and in humans (6-12). The extraction of this 
tracer by the myocardium and its subsequent clearance from 
myocardial tissue yield information on regional usage and 
metabolism of free fatty acids in terms of immediate oxi-
dation and intermediate storage in the myocyte. 
Use of C-II palmitic acid may, therefore, allow evalu-
ation of the metabolic state of the postischemic myocardium 
and prediction of metabolic and functional recovery. The 
purpose of this study was to evaluate the extraction and 
subsequent clearance of C-ll palmitic acid in canine myo-
cardium during and after a transient coronary occlusion to 
examine the effect of transient ischemia on myocardial fatty 
acid metabolism. In a subset of animals, we compared the 
tissue kinetics of C-ll palmitic acid with segmental myo-
cardial function to correlate metabolic and functional re-
covery after an ischemic injury. 
Methods 
Experimental preparation. Thirty mongrel dogs 
weighing 22 to 29 kg (mean 25.7) were anesthetized with 
sodium pentobarbital (25 mg/kg body weight) after an over-
night fast, intubated and ventilated with room air. Catheters 
were advanced through the femoral artery into the aorta for 
monitoring systemic blood pressure (Statham P23 Db strain 
gauge) and withdrawal of arterial blood. A catheter was 
placed into the femoral vein for injecting drugs and kept 
open with isotonic saline solution. After a left thoracotomy, 
the pericardium was widely incised and sutured to the chest 
wall to form a cradle in which the heart was suspended. 
Radiolabeled microspheres were injected through a poly-
vinyl cannula positioned in the left atrium. An electromag-
netic flow probe (Series 500, Biotronix) and an occlusive 
snare were placed around the left anterior descending coro-
nary artery distally to the first diagonal branch. A 25 gauge 
needle connected to a fine plastic tubing was then inserted 
into the left anterior descending artery 2 to 3 cm distal to 
the occlusive snare for intracoronary administration of C-
II palmitic acid. 
In a subset of six animals, ultrasonic crystals were placed 
subendocardially into the myocardium supplied by the left 
anterior descending coronary artery to monitor segmental 
systolic shortening with a sonomicrometer (Triton Inc.) (13). 
For ventricular pressure measurements, an additional 5 to 
7 cm long fluid-filled catheter was advanced in these animals 
through the apex into the left ventricle. Intracavitary pres-
sure recordings aided in defining end-diastole and end-sys-
tole for dimension measurements by ultrasonic crystals. An 
electrocardiogram, arterial and left ventricular pressures, 
segmental length and shortening and left anterior descending 
coronary flow were recorded continuously on an eight-chan-
nel strip chart recorder (Brush 200, Gould Inc.). 
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Myocardial C-ll palmitic acid activity. After instru-
mentation and a recovery period of 30 minutes, C-ll pal-
mitic acid, contained in a 0.1 to 0.3 m16% albumin solution, 
was flushed as a bolus into the left anterior descending artery 
with 2 ml of saline solution using the intracoronary needle. 
The specific activity was approximately 7 Ci/mmol (14). 
The mass of injected C-Il palmitic acid was therefore less 
than 100 nmoles and represented only tracer amounts. Myo-
cardial C-li tissue activity was recorded with a 100 ms 
temporal resolution for 60 minutes with a collimated 7.5 by 
5.0 cm NaI (Tl) scintillation probe positioned over the 
anterior wall of the left ventricle and connected to a com-
puter (Scintigraphic Data Analyzer 5407, Hewlett-Packard). 
Recorded counts were corrected for physical decay of C-ll 
activity (half-life of C-ll is 20.4 minutes) with time 0 at 
time of injection. 
Experimental protocol. The dogs were divided into three 
groups: In Group I (6 animals), the stability of the animal 
preparation and reproducibility of tissue C-ll time-activity 
curves over a 5 to 6 hour period were examined. C-ll 
palmitic acid was administered repeatedly at 70 to 90 min-
ute (3.5 to 4.5 half-times of C-ll) intervals and time-
activity curves were recorded. The activity concentration of 
the bolus was increased with each consecutive injection to 
minimize contributions of residual activity from the previous 
injection to the tissue time-activity curve. Myocardial blood 
flow was determined with radioactive microspheres before 
the first and again after the last injection of C-ll palmitic 
acid. 
In Group II (6 animals), the effects of a permanent 
coronary artery ligation on the tissue kinetics of C-ll pal-
mitic acid were evaluated. The tracer was injected at control 
and at 40, 110 and 200 minutes after permanent ligation of 
the left anterior descending coronary artery. 
In Group III (18 animals), the changes in the tissue 
kinetics of C-II palmitic acid during reperfusion after a 20 
minute coronary occlusion were examined. The tracer was 
injected at control and at 20,90 and 180 minutes after release 
of the coronary occlusion. Eight dogs in this group were 
excluded from further analysis because of ventricular fi-
brillation that occurred in one during occlusion and in the 
other seven during reperfusion. Myocardial blood flow was 
determined with radioactive microspheres in Groups II and 
III at control, at 10 minutes of occlusion and after the last 
C-Il palmitic acid injection. Arterial blood samples for 
determining plasma substrate concentrations were obtained 
from the left atrium before each injection of C-li palmitic 
acid. 
Myocardial tissue samples. At the end of each exper-
iment, the territory of the left anterior descending artery 
was identified with 2 ml of Lissamine green (K and K 
Laboratories, Inc.) injected through the intracoronary needle. 
The animals were then killed with concentrated potassium 
chloride and the heart rapidly removed. Green-stained myo-
cardium was carefully dissected and divided into endocar-
lACC Vol. 6, No.2 
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dial and epicardial samples. Tissue samples were also ob-
tained from control myocardium and treated in the same 
manner. All samples were placed in disposable tubes and 
weighed and the activity of the various labeled microspheres 
was determined in a well counter (Multichannel analyzer, 
Tracor Inc.). 
Calculation of blood flow and plasma substrate lev-
els. Regional myocardial blood flow was determined with 
radioactive labeled microspheres (15 ± 5 /-L in diameter; 
New England Nuclear) and the arterial reference technique 
(15). Plasma concentrations of total free fatty acid and lac-
tate were measured enzymatically (16,17) and glucose was 
measured with the oxidative rate method (18). 
Data analysis. An example of a myocardial C-II time-
activity curve is shown in Figure I. Uptake and clearance 
of C-II activity are shown in a low time resolution mode 
where each curve point represents the average activity for 
15 second samples and is normalized to counts/s. The inset 
of Figure I depicts the high frequency events early after 
tracer injection in a high time resolution mode (0.5 second 
sampling per curve point). 
Peak activity (A) is proportional to the total activity in-
jected. Carbon-II activity in myocardial tissue subsequently 
decreases in several phases. The initial steep phase reflects 
Figure 1. Analysis of C-II time-activity curves. The tissue data 
are displayed over a time period of 2,400 seconds (each curve 
point is a 15 second sampling). Retention fraction (RF) was derived 
from the high temporal resolution curve obtained in the first 100 
seconds (inset). Peak activity (A) is proportional to the total activity 
injected. Retention fraction (RF) was calculated by extrapolating 
the slow phase back to time of peak activity (A). As shown by 
the slow temporal resolution curve, the tissue clearance of C-II 
is best described by a biexponential fit with an early phase (EP) 
and a late phase (LP). Each curve component can be defined by 
its half-time and relative size. The relative size of each curve 
component was defined at the time of peak activity as the relative 
contribution of counts at the intercept of the early and late phase 
to the total counts A 1 (see text for details). 
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clearance of nonretained C-II palmitic acid from the vas-
cular and interstitial spaces. It has been defined as phase 1 
by others (10) and is usually completed within 20 to 25 
seconds. A slight delay in clearance ensues. This part has 
been defined earlier as "hump" (6) or as phase 2 (10). It 
is followed by two other characteristic tissue clearance com-
ponents, an early rapid phase and a late slow clearance phase 
(6). Both have also been defined as phases 3 and 4 (10) and 
are best appreciated on the low time resolutioh display in 
Figure I. According to earlier studies, these early rapid and 
late slow clearance phases reflect the fate of metabolically 
retained C-II palmitic acid. These studies suggest that the 
early rapid phase probably represents the fraction of C-II 
palmitic acid that enters oxidation and its rate of oxidation, 
whereas the late slow phase largely reflects the fraction of 
tracer that has been esterified and its rate of turnover (6). 
The initial capillary transit retention fraction (RF) (that 
is, the fraction of tracer retained in myocardium after a 
single pass through the coronary circulation) was determined 
by extrapolating the slope of the slower phase of the time-
activity curve back to the time of maximal activity (A) 
(inset, Fig. I). The retention fraction was then derived from 
counts at intercept B divided by maximal counts A. The 
first capillary transit unidirectional extraction fraction of C-
II palmitic acid (that is, the fraction of tracer that crosses 
the capillary membranes during a single pass of bolus through 
the coronary circulation) and the vascular clearance or back 
diffusion half-times were not estimated because back dif-
fusion of tracer from tissue into the vascular space coincides 
with the vascular and early metabolic clearance phase and 
precludes separate analysis of each of these processes. 
The two monoexponential tissue components, the early 
rapid phase and the late phase, were anaiyzed by biexpo-
nential least square curve fitting. The slope of each was 
defined by the corresponding half-times. The relative size 
of each component was determined by back extrapolation 
of the monoexponential slope of each component to the time 
of peak activity (A) as derived from the high temporal res-
olution curve (inset). The size of the early rapid and late 
slow phases was then calculated by dividing the counts at 
the intercepts of each slope by the maximal activity (A 1) 
derived from the extrapolated tissue curve. The resulting 
variables of the C-II time-activity curve were retention 
fraction, half-time and relative size of an early and late C-
II clearance phase. 
Statistical analysis. All mean values are given with their 
standard deviations. Analysis of variance was used to test 
differences within each group of experiments. A probability 
value of less than 0.05 was considered statistically significant. 
Results 
Group I (control). In the six control dogs, heart rate 
and blood pressure remained constant over the 5 hour study 
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Table 1. Hemodynamics and Myocardial Blood Flow at Control, During Occlusion and at the 
End of the Experiment 
Control 
HR (beats/min) 
BP (mm Hg) 
MBF (ml min I 100 g-I) 
Epi 
Endo 
Occlusion 
(Groups II & III only) 
HR (beats/min) 
BP (mm Hg) 
MBF(mlmin- 1 l00g- l ) 
Epi 
Endo 
End of experiment 
HR (beats/min) 
BP (mm Hg) 
MBF (mt min-I 100 g-I) 
Epi 
Endo 
Group I 
(control) 
(n = 6) 
150 ± 17 
131 ± 17 
80.8 ± 34.2 
89.6 ± 40.1 
148 ± 12 
135 ± 13 
151 ± 22 
135 ± 12 
96.2 ± 28.9 
91.2 ± 33.4 
Group II 
(complete 
occlusion) 
(n = 6) 
140 ± 13 
145 ± 27 
79.2 ± 29.9 
87.7 ± 42.1 
141 ± 12 
143 ± 19 
23.2 ± 9.4* 
9.4 ± 5.2* 
146 ± II 
140 ± 12 
19.7 ± 5.4* 
6.7 ± 3.4* 
Group III 
(reperfusion) 
(n = 10) 
131 ± 22t 
124 ± 21 
73.3 ± 17.4 
74.4 ± 22.5 
137 ± 25 
116 ± 17t:j: 
19.5 ± 17.4* 
10.5 ± 8.7* 
125 ± 29::: 
118 ± 19+ 
72.6 ± 23.4+ 
69.5 ± 23.1:j: 
*p < 0.05 compared with control values in the same group; tp < 0.05 compared with values in Group I; 
:J:p < 0.05 compared with values in Group II. BP = systolic blood pressure; HR = heart rate; MBF = 
myocardial blood flow in the epicardial (epi) and endocardial (endo) layers. 
period. Blood flow in the epicardial and endocardial layers 
of the myocardium supplied by the left anterior descending 
coronary artery was similar at the beginning and end of the 
experiment (Table I). Serial myocardial C-II tissue clear-
ance curves after intracoronary C-II palmitic acid injections 
in a control dog are shown in Figure 2 (top). The initial 
GROUP I: CONTROL 
10 Figure 2. Examples of serial tis-
M 
0 Control 90 min 180 min 270 min sue time-activity curves recorded ~ 
" after intracoronary C-II palmitic .. acid administration in individual ~ 
3.7 min 3.5 min 4.1 min 4.0 min dogs in the control group (Group :> 
0 62.0 % 52.0 % 61.0 % 62.0 % 0 I, top), the group with permanent 
coronary artery ligation (Group II, 
GROUP II: PERMANENT OCCLUSION 
center) and the group with 20 min-
utes of coronary occlusion (Group 
10 ~ III, bottom). For each experimen-M 0 Control 110 min 200 min tal run, the clearance half-time of ~ " the early rapid phase is given in .. minutes and its relative size in per--c 3.8 min 1 5.4 min 5.9 min 5.7 min cent of C-II palmitic acid retained :> 0 56.0 % 29.0 % 26.0 % 0 26.0 % in myocardium. In Group I, the in-
jections were given at 90 minute 
GROUP III: REPERFUSION 
intervals; in Group II, C-II pal-
mitic acid was injected at control 
M 
10 and at 40, 110 and 200 minutes 
0 Control 20 min 90 min 180 min after ligation of the coronary ar-~ 
~ tery. The Group III time-activity 
! curves were recorded at control and c 
5.0 min 5.8 min 5.0 min :> 2.9 min at 20, 90 and 180 minutes after 0 65.0 % 35.0 % 60.0 % 63.0 % 0 reperfusion. 
0 20 40 60 0 20 40 60 0 20 40 60 0 20 40 60 
Time in Minutes 
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Table 2. Retention Fractions (RF). Clearance Half-times of the Early Phase (ET 'h) and Late 
Phase (LT 'Ie). Relative Sizes of the Early Rapid Phase (EPS) and Late Phase (LPS) in Groups 
I, II and III 
Group I Group II Group III 
(n = 6) (n = 6) (n = 10) 
Run I 
RF(%) 49.2 ± 9.7 46.3 ± 9.1 48.7 ± 12.2 
ET ,!, (min) 4.4 ± 1.5 3.7 ± 0.8 4.8 ± 1.1 
EPS (%) 61.1 ± 9.9 52.4 ± 9.4 57.7 ± 9.2 
LT ,!, (min) 240.0 ± 166.9 227.7 ± 83.7 306.3 ± 176.3 
LPS (%) 38.9 ± 9.9 47.6 ± 9.4 42.3 ± 9.2 
Run 2 
RF(%) 48.0 ± 10.2 45.2 ± 10.5 51.4 ± 12.7 
ET '/' (min) 4.1 ± 1.3 4.9 ± 0.9* 7.1 ± 2.5* 
EPS (%) 62.5 ± 7.4 21.8 ± 4.8* 39.6 ± 9.5* 
LT '/' (min) 209.7 ± 109.8 231.2 ± 74.6 214.7 ± 113.5 
LPS(%) 37.5 ± 7.4 78.2 ± 4.8* 60.4 ± 9.5* 
Run 3 
RF(%) 52.9 ± 8.9 50.2 ± 12.02 51.0 ± 11.1 
ET '/' (min) 5.3 ± 2.2 6.9 ± 3.8* 7.9 ± 3.0* 
EPS (ek) 62.9 ± 10.7 29.5 ± 11.5* 45.2 ± 13.2* 
LT '/' (min) 296.4 ± 138.8 289.2 ± 144.3 248.4 ± 159.7 
LPS (%) 37.1 ± 10.7 70.5 ± 11.5* 54.8 ± 13.2* 
Run 4 
RF (%) 51.7 ± 11.7 53.3 ± 10.1 49.5 ± 10.1 
ET ,!, (min) 5.1 ± 1.5 5.9 ± 1.9* 8.7 ± 2.4* 
EPS (%) 61.0 ± 8.9 22.6 ± 4.9* 49.6 ± 9.6 
LT '/' (min) 479.5 ± 273.7 233.7 ± 103.5 400.9 ± 330.5 
LPS (%) 39.0 ± 8.9 77.4 ± 4.9* 50.4 ± 9.6 
*p < 0.05; values are compared with control (run I). In Group I. all experimental runs were performed 
under control conditions. In Group II. run I represents the control study while runs 2. 3 and 4 were performed 
at 40. 110 and 200 minutes after ligation. In Group III. run I was performed at control and runs 2. 3 and 4 
at 20. 90 and 180 minutes after release of the left anterior descending coronary artery ligation. All values are 
expressed as mean ± I SD. 
capillary transit retention fraction of C-II palmitic acid. 
tissue clearance half-times and the relative size of the early 
and late phases remained constant over the 5 hour study 
period (Table 2. Fig. 3). 
Group II (permanent coronary occlusion), In the six 
animals with permanent left anterior descending artery oc-
clusion. the heart rate and blood pressure at 40. 110 and 
200 minutes of occlusion did not differ significantly from 
Figure 3. Mean values of the serially measured 
clearance half-times and relative sizes of the early 
phase for Group I. II and III dogs. Hatched 
bars represent data obtained in the control stud-
ies and the open bars represent studies after 
interventions. *p < 0.05; **p < 0.01; C = 
control; OC = occlusion; Rep = reperfusion; 
SO = standard deviation. 
15 
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control values. Blood flow in the territory of the left anterior 
descending artery decreased after occlusion of this vessel 
to 29.4 and 10.7% of control in the epicardial and the 
endocardial layers, respectively. No significant changes in 
these values occurred from early to late after occlusion (Ta-
ble I). Serial tissue C-li time-activity curves in a Group 
II dog are shown in Figure 2 (center). The initial capillary 
transit retention fraction of C-II palmitic acid was similar 
at control and at 40, 110 and 200 minutes after occlusion. 
The clearance half-times of the early phase were markedly 
longer at 40, 110 and 200 minutes of occlusion than at 
controL The relative size of the early rapid phase decreased 
after occlusion without changing significantly between the 
serial post-occlusion experiments (Table 2, Fig. 3). There 
was, however, no significant change in the clearance half-
time of the late phase. 
Group III (coronary reperfusion). For the 10 animals 
with transient 20 minute coronary occlusion, mean systolic 
blood pressure and heart rate at control, during occlusion, 
and at 20, 90 and 180 minutes of reperfusion are listed in 
Table 1. No significant differences among control, occlusion 
and reperftision periods were observed. Blood flow in the 
territory of the left anterior descending coronary artery de-
creased during occlusion to 30.1 % of control in the epi-
cardial and to 16.3% of control in the endocardial layer but 
had returned to 100% of control at the end of the reperfusion 
period. 
Serial tissue C-II time-activity curves in a Group Jll dog 
are shown in Figure 2 (bottom). Compared with control, 
the initial capillary transit retention fraction of C-II palmitic 
acid during the reperftision period remained unchanged, and 
the clearance half-times of the early rapid phase increased. 
At 180 minutes of reperfusion half-times were still longer 
than at control. The relative size of the early rapid phase 
was most markedly reduced during the early reperfusion 
period but increased over time and no longer differed from 
control at 180 minutes of reperfusion (Table 2, Fig. 3). 
Reperfusion had no statistically significant effect on the 
clearance half-times of the late phase of the time-activity 
curve. 
In 6 of the 10 Group Jll dogs, in which segmental frac-
tional shortening and end-diastolic length in the left anterior 
descending artery were measured, regional function was 
most severely depressed during the occlusion period (Table 
3). Regional function improved slowly with reperfusion, 
but remained significantly below control at 180 minutes of 
reperfusion. 
Arterial plasma substrate levels. Because changes in 
plasma concentrations cause proportionate changes of myo-
cardial substrate utilization (18) and, hence, could modify 
fractional tissue distribution and clearance half-times of C-
II palmitic acid, arterial plasma substrate levels were de-
termined in all experiments (Table 4). No significant changes 
occurred except for a moderate increase in lactic acid con-
lACC Vol. 6. No.2 
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Table 3. Regional Segmental Shortening (FS) and End-diastolic 
Length (EDL) in the Left Anterior Descending Coronary Artery 
Territory in Six Group III Dogs 
EDL (mm) FS (%) 
Control 12.8 ± 3.2 15.1 ± 4.9 
Occlusion 14.1 ± 3.8* - 2.6 ± 3.2* 
Reperfusion 
20 min 14.4 ± 4.1* 0.5 ± 4.3* 
90 min 13.6 ± 3.8* 3.4 ± 2.9* 
180 min 13.4 ± 3.7 5.9 ± 3.7 
*p < 0.05; values are compared with control. All values are expressed 
as mean ± I SD. 
centrations during the early reperfusion period in Group III 
dogs. 
Discussion 
Our findings indicate that changes in the myocardial up-
take and clearance of C-ll palmitic acid can demonstrate 
beneficial effects of reperfusion after transient ischemia. 
Accordingly, C-ll palmitic acid used with positron emis-
sion tomography should allow external evaluation of the 
metabolic consequences of an ischemic injury and myo-
cardial reperfusion. 
Methodologic considerations. Retention and subse-
quent turnover of C-ll palmitic acid in myocardial tissue 
were evaluated after delivery of a small tracer bolus directly 
into the coronary artery. This approach has been previously 
employed and validated in our laboratory (6,12,19). Intra-
coronary was preferred to systemic tracer administration for 
several reasons. The amount of tracer delivered to the vas-
cular bed of the coronary artery can be easily measured from 
the peak activity of the time-activity curve. Second, because 
of the high first capillary transit retention fraction of C-ll 
palmitic acid, only a small amount of tracer reaches the 
systemic circulation. The tracer is rapidly diluted in the 
systemic circulation. Therefore, recirculation of C-ll ac-
tivity is confined to the very early time period of tissue 
activity recording (that is, the initial 20 seconds) (19). Rapid 
blood sampling in the left ventricle after the bolus injection 
of tracer into the coronary artery revealed a fast decrease 
of tracer concentration to less than 3% of peak activity 
within I to 2 minutes after injection. Because the detector 
probe views the entire heart, rapid clearance of tracer ftom 
blood is important to minimize contamination of the tissue 
time-activity curve. Furthermore, contamination of the 
myocardial time-activity curve from other sources, for ex-
ample, the liver, is negligible because only a minute fraction 
of tracer injected into the left anterior descending coronary 
artery reaches the liver. Consequently, the time-activity re-
corded by the scintillation probe almost exclusively reflects 
activity originating from myocardium supplied by the left 
anterior descending coronary artery. 
lACC Va!. 6, No.2 
August 1985:311-20 
SCHW AlGER ET AL. 
C-II PALMITIC ACID KINETICS 
317 
Table 4. Arterial Plasma Concentrations of Glucose, Lactate and Fatty Acids 
Run I Run 2 Run 3 Run 4 
Group I 
Glucose 
Lactate 
FFA 
105.2 ± 10.7 
11.3 ± 6.2 
0.31 ± 0.2 
99.4 ± 9.X 
9.0 ± 3.4 
0.27 ± 0.17 
99.3 ± 11.2 
9.0 ± 4.2 
0.30 ± 0.13 
109.7 ± 13.4 
8.3 ± 4.4 
0.27 ± 0.19 
Group II 
Glucose 
Lactate 
FFA 
91.2 ± 9.7 
11.5 ± 4.3 
0.25 ± 0.2 
84.0 ± 8.9 
10.5 ± 5.0 
0.17 ± 0.12 
90.0 ± 9.2 
8.5 ± 3.9 
0.17 ± 0.D7 
98.0 ± 8.7 
6.9 ± 4.9 
0.24 ± 0.16 
Group III 
Glucose 
Lactate 
FFA 
96.5 ± 11.1 
6.4 ± 4.7 
0.36 ± 0.14 
100.4 ± 14.6 
10.9 ± 9.8 
0.44 ± 0.09 
92.3 ± 20.1 
5.3 ± 7.3 
0.30 ± 0.16 
91 ± 17.2 
2.4 ± 1.6 
31 ± 0.16 
Values for glucose and lactate are given in mg/lOO ml and for total free fatty acids (FFA) in mEq/liter. 
Carbon-II activity cleared from myocardium in a char-
acteristic multiexponential fashion. This clearance pattern 
implies distribution in myocardium between at least two 
pools with different turnover rates. Myocardial metabolism 
of free fatty acids is obviously more complex. A multicom-
partmental tracer kinetic model would be required for ac-
curately describing the various metabolic pathways of free 
fatty acid in myocardium and the fate of the label in tissue. 
Within the time constraints of data acquisition imposed by 
the short physical half-life of C-ll and in light of the ob-
served clearance pattern of C-ll activity from myocardial 
tissue, the biexponential curve-fitting procedure and de-
scription of the two major curve components by their relative 
size and clearance half-time is a practical though simplified 
means for analyzing the time-activity curves. In fact, the 
early rapid clearance phase corresponds qualitatively and 
quantitatively to the release of C-ll carbon dioxide as the 
end-product of oxidation of C-II palmitic acid as demon-
strated previously in our laboratory (5,6,20). Thus, the early 
rapid phase appears to primarily reflect the fraction of tracer 
that is oxidized immediately, whereas the late slow clear-
ance phase probably relates to tracer deposited in the en-
dogenous lipid pool. 
Interpretation of experimental observations. The re-
sults obtained in the control animals (Group I) are in good 
agreement with those previously observed in our laboratory 
(6,20). Myocardium retained approximately 50% of the in-
jected C-ll palmitic acid during a single capillary transit. 
Of this, about 55% enters the rapid turnover pool with a 
half-time of approximately 4 minutes. The remaining 45% 
of activity clears with a slower half-time of more than 200 
minutes. The results of the serial studies in the control group 
demonstrate the reproducibility of the measurements over a 
time period of 5 hours and the metabolic and hemodynamic 
stability of the open chest preparation. Previous investiga-
tions (6,20) using C-II palmitic acid have shown effects of 
substrate availability and cardiac work load on tracer ki-
netics. The hemodynamic and biochemical measurements 
in this study reveal no significant alterations of these vari-
ables within all three groups of animals. Therefore, changes 
in substrate availability or work load cannot account for the 
observed changes within each experimental group. 
Both permanent coronary occlusion in the Group 11 ex-
periments and the release of occlusion in the Group 111 
experiments significantly altered the fractional tracer dis-
tribution and clearance half-times. The initial capillary transit 
retention fraction of C-Il palmitic acid remained constant, 
a finding consistent with previous results during ischemia 
and hypoxia in canine myocardium (9,12). Several mech-
anisms for transmembraneous exchange of free fatty acids 
have been proposed. The favored mechanism is passive 
diffusion (21). The unchanged initial retention fraction of 
C-II palmitic acid in ischemic or reperfused myocardium, 
however, does not preclude back diffusion of C-Il palmitic 
acid that was not activated to acyl-coenzyme A. A relative 
increase of back diffusion has been observed in ischemic 
myocardium (11,22). The assessment of the amount of C-
II palmitic acid leaving the cell from the time-activity curves 
is limited because the rates of metabolic turnover and back 
diffusion may be similar and deconvolution of both com-
ponents would therefore be difficult. 
The observed prolongation of the clearance half-time of 
the early phase and increase in the size of the late phase 
during ischemia in Group 11 experiments can be explained 
by a decreased rate of fatty acid oxidation, larger volume 
of distribution and, accordingly, an increase of the endog-
enous lipid pool. Cytosolic concentrations of nonactivated 
and activated free fatty acids are known to increase with 
ischemia (4). Both tissue clearance and fractional distri-
bution remained abnormal throughout the study period of 
200 minutes of occlusion, which suggests a stable metabolic 
pattern during ischemia. 
In contrast, release of the coronary occlusion after 20 
minutes and restoration of blood flow in the Group III ex-
periments markedly altered the tissue kinetics. The relative 
size of the early rapid phase was already 74% larger after 
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20 minutes of reperfusion than in the permanent Group II 
occlusion experiments. The size of this curve component 
progressively increased with time. After 180 minutes of 
reperfusion, it no longer differed significantly from control, 
suggesting that the mechanism controlling the fractional 
distribution of tracer, and possibly of free fatty acid, be-
tween the two turnover pools recovered rapidly as blood 
flow was restored. 
Unexpectedly, the tracer clearance rates progressively 
decreased with time. Average clearance half-times were 
48% at 20 minutes and 80% longer at 180 minutes of re-
perfusion than at control. The clearance rate of the tracer 
depends on several factors. Removal of carbon dioxide from 
tissue is largely a function of blood flow. The removal rate 
is expected to be much faster (in seconds even at low flows) 
than the rate of carbon dioxide production. Therefore, re-
tention of C-II-Iabeled carbon dioxide is unlikely to ac-
count for the progressive increase in clearance half-times. 
Another explanation is a progressive increase in the distri-
bution volume of C-II palmitic acid or its metabolic inter-
mediates. Intracellular levels of metabolic intermediates of 
free fatty acids should progressively increase during reper-
fusion, at least during the initial phase, a hypothesis that 
needs further confirmation by tissue assay of free fatty acid 
metabolic intermediates. 
Spatial and temporal heterogeneity in the degree of isch-
emia provide an alternate explanation. The microsphere 
measurements indicate heterogeneously reduced blood flow 
with lowest values in the subendocardial layers. Because 
the recorded time-activity curves represent transmural in-
formation, different degrees of recovery in the epicardium 
and endocardium cannot be resolved. Therefore, immedi-
ately after reperfusion relatively more tracer was delivered 
to less severely injured myocardium. As blood flow and 
metabolism recovered in the endocardial layers, their con-
tribution to the time-activity curve increased. Because of 
slower recovery of fatty acid metabolism in these segments 
and their increasing contribution to the overall time-activity 
curves with reperfusion, the tissue clearance half-time could 
progressively lengthen. Although the latter mechanism would 
be consistent with slow recovery of segmental myocardial 
fatty acid metabolism, this explanation could have been 
proven only by extending the experimental protocol for sev-
eral hours with additional injections of tracer. However, 
prolongation of the open chest dog experiments beyond the 
already 7 to 8 hour period would have been unrealistic and 
logistically difficult. 
Finally, it is known that back diffusion of C -J J palmitic 
acid increases during ischemia (9,12,22). Because back 
diffusion and the rapid metabolic clearance of C-ll label 
may have similar rates, the lengthening of clearance rates 
after reperfusion may represent a decrease of back diffusion 
over time and, hence, a smaller contribution to the early 
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part of tissue clearance unmasking the true metabolic rate. 
Decrease of back diffusion could be consequently inter-
preted as recovery of cell function. 
Because of these considerations, the relative size of the 
late phase as an estimate of the fraction of free fatty acid 
deposited in the endogenous lipid pool may be a better index 
for metabolic recovery because it is less sensitive than the 
clearance rate. Our results indicate that there is a gradual 
decrease of the relative size of the late phase consistent with 
recovery of factors determining the distribution of C-ll 
palmitic acid between immediate oxidation and storage in 
endogenous lipid pools. 
Regional function versus myocardial energy metab-
olism. Additionally, measurements of regional function 
provide some evidence that the observed changes in tracer 
tissue kinetics did indeed reflect metabolic improvement. 
In the six dogs instrumented with ultrasonic crystals, frac-
tional shortening in the territory of the left anterior descend-
ing coronary artery had returned at the end of the reperfusion 
Figure 4. Serial changes in C-II palmitic acid kinetics and seg-
mental function in dogs with subendocardially implanted ultrasonic 
crystals. EDL = end-diastolic length; FS = fractional shortening 
derived from end-diastolic minus end-systolic length divided by 
end-diastolic length; RS = relative size of the early rapid phase; 
T 11> = clearance half-time of the early rapid phase. The cross-
hatched bars at the left of each panel represent measurements at 
control (C), the shaded bars (second from left) measurements 
during occlusion (OC) and the open bars (bars 3 to 5) measure-
ments at 20. 90 and 180 minutes after reperfusion (Rep). 
*p < 0.05. 
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experiment to 39% of control, and the relative size of the 
early rapid phase had improved to 84% of control (Fig. 4). 
The difference in magnitude in the degree of improvement 
of both variables may be explained by several factors. Func-
tion was measured in the subendocardial layer where, as 
indicated by blood flow measurements, ischemic injury was 
most severe. Second, uptake and subsequent clearance of 
C-ll palmitic acid are related to myocardial fatty acid me-
tabolism, which is only indirectly linked to contractile func-
tion. The heart derives high energy phosphates not only 
from free fatty acids, but also from oxidation of other sub-
strates like glucose, lactic acid and ketone bodies. There-
fore, evaluation of myocardial metabolism with C-ll pal-
mitic acid is only inherently incomplete. Lastly, accumulation 
of metabolic free fatty acid intermediates, a possibility sug-
gested by the progressive delay in C-ll tissue clearance, 
can interfere with myocardial energy metabolism. Increased 
mitochondrial acyl-coenzyme A levels inhibit adenosine 
diphosphate-adenosine triphosphate translocation from mi-
tochondrial to cytosol and, thus, could impair the mito-
chondrial energy transduction system (23,24). The benefi-
cial effect of carnitine on free fatty acid metabolism and 
mechanical function in the ischemic heart suggests such a 
relation between compromised free fatty acid metabolism 
and contractile function (25-28). 
Conclusions. Our data demonstrate that effects of isch-
emia and reperfusion on regional myocardial metabolism 
can be evaluated with C-ll palmitic acid. The tissue kinetics 
of C-ll palmitic acid after transient ischemia return only 
slowly toward normal, suggesting the delayed recovery of 
fatty acid metabolism. The distinction between ischemic and 
postischemic myocardium with C-ll palmitic acid and pos-
itron emission tomography may be useful in patients with 
coronary artery disease to allow evaluation of the severity 
and extent of an ischemic injury as well as beneficial effects 
of therapeutic interventions such as thrombolysis in patients 
with acute myocardial infarction. 
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